Stock Screener App

Frei -

Installieren

0.2992

3.64% -0.0113

Vyne Therapeutics Inc (VYNE)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Finanzdaten der Vyne Therapeutics Inc-Aktie (VYNE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	65.84% 0.069	0.202	0.084	0.121	0.198
Operating Expenses	19.02% 7.611	9.399	12.85	13.21	10.59
Benefits Costs and Expenses	33.95% 5.816	8.805	12.09	12.28	9.593
Costs And Expenses	19.02% 7.611	9.399	12.85	13.21	10.59
Operating Income/Loss	17.99% -7.542	-9.197	-12.77	-13.09	-10.40
Income/Loss From Continuing Operations Before Tax	33.20% -5.747	-8.603	-12.01	-12.16	-9.395
Income Tax Expense/Benefit	-	-	0.004	-	-
Income/Loss From Continuing Operations After Tax	33.20% -5.747	-8.603	-12.01	-12.16	-9.395
Income/Loss From Discontinued Operations, Net Of Tax	0.00% -0.008	-0.008	-0.008	-	-0.011
Net Income/Loss	33.17% -5.755	-8.611	-12.02	-12.16	-9.406
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.20% 42.76	42.67	-0.003	42.59	42.59
Diluted Average Shares	0.20% 42.76	42.67	-0.003	42.59	42.59
Basic Earnings Per Share	35.00% -0.13	-0.20	-0.28	-0.29	-0.22
Diluted Earnings Per Share	35.00% -0.13	-0.20	-0.28	-0.29	-0.22
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$86.64

1.40%

GMAB

$27.54

0.58%

SMMT

$25.98

9.16%

BNTX

$112.46

8.66%

INSM

$145.10

1.80%

ONC

$341.80

7.24%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters